Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Sign Up to like & getrecommendations! Published in 2017 at "Thorax"
DOI: 10.1136/thoraxjnl-2016-208710
Abstract: Rationale There is no consensus as to when treatment for idiopathic pulmonary fibrosis (IPF) should be initiated. Some physicians prefer not to treat patients with preserved lung volume. Objective To investigate whether patients with IPF… read more here.
Keywords: lung volume; preserved lung; fvc predicted; volume ... See more keywords